Cryo Cell International (CCEL) Cash & Equivalents (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Cash & Equivalents data on file, last reported at $249672.0 in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $249672.0, up 11.9% year-over-year; the trailing twelve-month figure through Feb 2026 was $249672.0 (up 11.9% YoY), and the FY2025 annual result was $319031.0, down 43.13% from the prior year.
• Cash & Equivalents fell to $249672.0 in Q1 2026 per CCEL's latest filing, from $319031.0 in the prior quarter.
• Over five years, Cash & Equivalents peaked at $2.9 million in Q3 2022 and troughed at $137491.0 in Q2 2025.
• A 5-year average of $925536.7 and a median of $469195.0 in 2024 frame the typical range for Cash & Equivalents.
• On a YoY basis, Cash & Equivalents climbed as much as 38.14% in 2024 and fell as far as 82.0% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $1.7 million in 2022, then plunged by 76.17% to $406067.0 in 2023, then soared by 38.14% to $560960.0 in 2024, then sank by 43.13% to $319031.0 in 2025, then declined by 21.74% to $249672.0 in 2026.
• Business Quant data shows CCEL's Cash & Equivalents at $249672.0 in Q1 2026, $319031.0 in Q4 2025, and $265207.0 in Q3 2025.